BioSpace News Archive

Q-State Biosciences (“Q-State”), today announced the publication of new research describing the successful design, screening and characterization of splice modulating antisense oligonucleotides (ASOs) as a potential therapeutic approach for SPG49/HSAN9 (spastic paraplegia 49, more recently classified as hereditary sensory and autonomic neuropathy type IX), an ultra-rare neurodevelopmental and neurodegenerative disorder.

Orthopedic Devices market business report contains a chapter on the universal Orthopedic Devices market and all its linked companies with their profiles, which presents valuable data pertaining to their outlook in terms of finances, product portfolios, investment plans, and marketing and business strategies.

Alkermes plc announced the results of its 2022 Annual General Meeting of Shareholders held July 7, 2022.

Vascular Surgery and Endovascular Procedures Market: Market Size, Share, Trends, Industry Analysis, Application Analysis, Growth and Forecast " provides a deep and thorough evaluation of the Vascular Surgery and Endovascular Procedures market based on its segments including type, end use and region.

A high-ranking Anticoagulation Therapy Market research report presents the solutions that empower to arrive at smart, fast, and precise decisions for the business so that it grows and surpasses their goals.

HaemaLogiX Ltd, a clinical stage immuno-oncology biotech developing novel immunotherapies for patients with blood cancers, is pleased to announce the appointment of Dr. Geoff Nichol to its Board as Non-Executive Director.

A NEW drug shown to significantly reduce the risk of cancer recurrence or death in an aggressive form of breast cancer is now approved by the Food and Drug Administration of the Philippines.

According to Vision Research Reports, the global Dermatology Devices market size is expected to be worth around US$ 55.3 billion by 2030.

According to Vision Research Reports, the global T-cell therapy market size is expected to be worth around US$ 20.8 billion by 2030 from valued at US$ 4.9 billion in 2021 and is anticipated to grow at a CAGR of 20.4% during forecast period 2022 to 2030.

According to Latest Study, the global placental stem cell therapy market was valued at US$ 0.9 billion in 2021 and is expected to reach US$ 4.7 billion by 2030 with a CAGR of 22% from 2022 to 2030.